T. Rowe Price Associates’s Lantronix LTRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$545K Buy
92,603
+43,881
+90% +$281K ﹤0.01% 2590
2026
Q1
$256K Hold
48,722
﹤0.01% 2749
2025
Q4
$286K Hold
48,722
﹤0.01% 2668
2025
Q3
$223K Hold
48,722
﹤0.01% 2750
2025
Q2
$140K Buy
48,722
+27,722
+132% +$63K ﹤0.01% 2820
2025
Q1
$53K Buy
21,000
+9,800
+88% +$31.6K ﹤0.01% 2919
2024
Q4
$47K Hold
11,200
﹤0.01% 2952
2024
Q3
$47K Hold
11,200
﹤0.01% 2937
2024
Q2
$40K Hold
11,200
﹤0.01% 2878
2024
Q1
$40K Hold
11,200
﹤0.01% 2895
2023
Q4
$66K Hold
11,200
﹤0.01% 2767
2023
Q3
$50K Hold
11,200
﹤0.01% 2781
2023
Q2
$48K Hold
11,200
﹤0.01% 2806
2023
Q1
$49K Hold
11,200
﹤0.01% 2793
2022
Q4
$48K Hold
11,200
﹤0.01% 2816
2022
Q3
$54K Hold
11,200
﹤0.01% 2827
2022
Q2
$60K Hold
11,200
﹤0.01% 2836
2022
Q1
$75K Hold
11,200
﹤0.01% 2884
2021
Q4
$88K Hold
11,200
﹤0.01% 2889
2021
Q3
$65K Hold
11,200
﹤0.01% 2891
2021
Q2
$58K Hold
11,200
﹤0.01% 2890
2021
Q1
$51K Buy
+11,200
New +$53K ﹤0.01% 2823

Other funds holding LTRX

T. Rowe Price Associates's LTRX Position: Q2 2026 in Review

T. Rowe Price Associates increased its Lantronix (LTRX) stake by 90% in Q2 2026, buying an estimated $281K and bringing the position to 92,603 shares worth $545K. The position accounts for ﹤0.01% of the portfolio, ranked #2590.

T. Rowe Price Associates first reported a position in LTRX in Q1 2021 and has held it in 22 quarters since. 122 funds tracked by Wall St. Rank hold LTRX as of Q2 2026.

  • T. Rowe Price Associates held 92,603 shares of Lantronix worth $545K as of Q2 2026.
  • T. Rowe Price Associates bought 43,881 Lantronix shares in Q2 2026, an estimated $281K.
  • Lantronix made up ﹤0.01% of T. Rowe Price Associates's portfolio in Q2 2026, its #2590 holding.
  • T. Rowe Price Associates first reported a position in Lantronix in Q1 2021 and has held it in 22 quarters since.
  • 122 funds tracked by Wall St. Rank held Lantronix as of Q2 2026.

Based on T. Rowe Price Associates's 13F filing for Q2 2026, filed 14 Aug 2026.